Rethinking autism and animal models: A systems perspective
Tag: mouse models
SFARI workshop highlighted chromatin-associated proteins and autism risk
On April 17, 2018, molecular neuroscientists and geneticists gathered at the Simons Foundation for a workshop on the role of chromatin-associated proteins in autism spectrum disorder. The workshop discussed the…
SFARI 2018 Explorer awardees announced
SFARI is pleased to announce that it expects to have funded 22 grants in response to the Explorer Awards request for applications (RFA) this year.
SFARI workshop revisited the excitation-inhibition hypothesis of autism
On May 15, 2018, SFARI convened a workshop to revisit the excitation/inhibition (E/I) hypothesis of autism, a synaptic-based account of the disorder that has been highly influential in the last…
Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials) — a European initiative to study autism — has launched
The Innovative Medicines Initiative, a European public-private initiative, recently awarded a €115 million five-year grant for autism research. The Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials) brings together 48 partners from academia,…
A Conversation with Paul Wang, Deputy Director of Clinical Research Associates
Paul Wang, Deputy Director of Clinical Research Associates, L.L.C. (CRA), discusses the research that CRA supports, including human and animal studies using arbaclofen, a potential drug treatment for autism.